COVID-FISETIN: Pilot in SARS-CoV-2 of Fisetin to Alleviate Dysfunction and Inflammation

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2020
The purpose of this study is to test whether Fisetin, a senolytic drug, can assist in preventing an increase in the disease\'s progression and alleviate complications of coronavirus due to an excessive inflammatory reaction.
Epistemonikos ID: 9b2c0770acf655f81e6041fc500f001eb0bfc6e4
First added on: Jul 21, 2020